1. Home
  2. MLP vs MREO Comparison

MLP vs MREO Comparison

Compare MLP & MREO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

MLP

Maui Land & Pineapple Company Inc.

HOLD

Current Price

$16.82

Market Cap

333.8M

Sector

Finance

ML Signal

HOLD

Logo Mereo BioPharma Group plc

MREO

Mereo BioPharma Group plc

HOLD

Current Price

$2.02

Market Cap

324.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MLP
MREO
Founded
1909
2015
Country
United States
United Kingdom
Employees
N/A
N/A
Industry
Real Estate
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
333.8M
324.6M
IPO Year
1972
N/A

Fundamental Metrics

Financial Performance
Metric
MLP
MREO
Price
$16.82
$2.02
Analyst Decision
Strong Buy
Analyst Count
0
5
Target Price
N/A
$7.20
AVG Volume (30 Days)
43.2K
2.4M
Earning Date
11-14-2025
11-10-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$18,344,000.00
$500,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$131.12
P/E Ratio
N/A
N/A
Revenue Growth
73.55
N/A
52 Week Low
$13.84
$1.47
52 Week High
$23.41
$3.88

Technical Indicators

Market Signals
Indicator
MLP
MREO
Relative Strength Index (RSI) 60.05 50.12
Support Level $16.52 $1.89
Resistance Level $17.46 $2.37
Average True Range (ATR) 0.58 0.17
MACD 0.06 -0.01
Stochastic Oscillator 65.84 40.48

Price Performance

Historical Comparison
MLP
MREO

About MLP Maui Land & Pineapple Company Inc.

Maui Land & Pineapple Co Inc is a landholding and operating company. ML&P owns, develops, sells, and manages residential, resort, commercial, agricultural, and industrial real estate. It operates in three segments: Land Development & Sales which includes land planning and entitlement, development, and sales activities; Leasing operations include residential, resort, commercial, agricultural, industrial land and property leases; and Resort Amenities segment, which include a membership program that provides certain benefits and privileges within the Kapalua Resort for its members. The majority of its revenue is derived from the Leasing segment. Leasing revenue is generated from restaurants, retail outlets, office buildings, warehouses, and other resort activities.

About MREO Mereo BioPharma Group plc

Mereo BioPharma Group PLC is a United Kingdom (U.K.) based biopharmaceutical company focused on the development of therapeutics for rare diseases. The company has developed a portfolio of late-stage clinical product candidates, and its two rare disease product candidates are setrusumab for the treatment of osteogenesis imperfecta (OI) and alvelestat primarily for the treatment of severe alpha-1 antitrypsin deficiency-associated lung disease (AATD-LD).

Share on Social Networks: